Exercise for GLP-1 Users. Built Around Your Biology.
Evidence-based programming informed by peer-reviewed research. See sources at the bottom of the page.Last updated: April 19, 2026
The scale is moving. Your body looks different. Not in the way you expected.
"I actually feel less firm, more wobbly and flabby. I seem to have less definition"
Voiced in r/GLP1 community discussions, 2026
That isn't vanity. Up to 39 percent of the weight you lose on a GLP-1 is lean mass (Prado et al., 2024). Most apps don't know you're on a GLP-1 and can't adapt. ZonalFit does.
What other apps get wrong about GLP-1 training
Zero apps have a GLP-1 mode.
You're just another weight-loss user as far as their programming is concerned, even though your physiology is meaningfully different. Appetite suppression plus rapid weight loss plus injection-day side effects aren't features any of them model.
"Anyone else having a hard time working out on Wegovy?"
Voiced in r/GLP1 community discussions, 2026
They optimize for calorie burn, not muscle retention.
The scale is already moving for you; that's not the problem you're trying to solve. The problem is the composition of what's leaving, and chronic cardio is the wrong lever.
They program for steady-state weekly intensity.
Injection day plus the 24 to 48 hours after often come with nausea, fatigue, and reduced appetite. A generic Tuesday HIIT block on injection day is a bad prescription. Most apps don't even know it's injection day.
How ZonalFit programs for GLP-1 users
1. Muscle preservation is the primary goal.
Resistance training plus adequate protein is the evidence-based intervention. In a meta-analysis of RCTs, resistance training attenuated 93.5 percent of caloric-restriction-induced lean-mass loss (Sardeli et al., 2018). Supervised resistance training over 10+ weeks adds roughly 3 kg of lean mass and 25 percent strength (Locatelli et al., 2024). ZonalFit biases GLP-1 users toward 3 to 4 lifting sessions per week with progressive loading.
"I swear I can feel my muscle being broken down. Is this a thing??"
Voiced in r/GLP1 community discussions, 2026
2. Progressive resistance with tracked strength as the outcome.
The engine tracks your main compound lifts week over week. If strength is holding or improving while weight is dropping, you're winning. If strength is falling, the engine flags it as a signal that protein, sleep, or training volume needs adjustment.
3. Injection-day scaling, automatically.
Tell ZonalFit when you inject. Injection day and the day after default to shorter sessions (20 to 25 minutes), reduced volume, no HIIT, no conditioning blocks. Full programming resumes on day 3. The engine works around your medication schedule, not against it.
4. Protein-intake coaching alongside training.
Muscle preservation requires both stimulus (training) and substrate (protein). Resistance training without adequate protein intake is still net catabolic during a caloric deficit (Cava et al., 2017). ZonalFit's coaching conversations include protein-intake guidance calibrated to your body weight and training load.
5. Zone 2 cardio, not chronic HIIT.
During a pharmacologic deficit, stacked HIIT adds stress without proportional benefit. Zone 2 steady-state cardio (conversational pace, 30 to 45 minutes, 1 to 3 sessions per week) supports cardiovascular health while protecting recovery.
6. Daily readiness-aware volume.
If your check-in flags nausea, low sleep, or low appetite (all common on GLP-1s), the engine scales volume down and prioritizes movement quality. You don't get penalized for a symptom day.
Frequently Asked Questions
-
Likely yes, at least in part. Without a resistance-training stimulus, 25 to 39 percent of the weight you lose on a GLP-1 comes off as lean mass over 36 to 72 weeks (Prado et al., 2024). The stairs test is a real signal, not hypochondria. Resistance training plus adequate protein is the evidence-based response (Locatelli et al., 2024), and it's what ZonalFit biases GLP-1 programming toward.
-
No. Protein is substrate; training is stimulus. Without the resistance-training signal, your body doesn't have a strong reason to direct amino acids toward muscle rather than other tissues. Both matter, and the evidence on combined RT plus protein is where the muscle-preservation effect actually lives (Cava et al., 2017; Sardeli et al., 2018).
-
Lighter. ZonalFit defaults to shorter sessions (20 to 25 minutes) with reduced volume and no HIIT on injection day and the day after. Full programming resumes on day 3. Nausea and fatigue are real and respected.
-
Walking counts. Even 20 to 30 minutes of walking on your worst day maintains the "I'm still training" signal. Don't force a lifting session through active nausea; the engine will pick things back up when your check-in clears.
-
No. Zone 2 steady-state cardio (conversational pace, 30 to 45 minutes) supports cardiovascular health during a deficit without the recovery cost of chronic HIIT. 1 to 3 zone 2 sessions per week is the sweet spot. -
Current consensus for active adults during weight loss is 1.2 to 1.6 grams per kilogram of body weight, with the higher end recommended during significant caloric deficit (Cava et al., 2017). On a GLP-1 with reduced appetite, this often requires deliberate planning and sometimes protein supplementation. Discuss with your clinician or a registered dietitian.
-
No. The Villareal 2017 NEJM RCT showed resistance plus aerobic training during weight loss produced equivalent fat loss to aerobic-only while preserving more lean mass and functional capacity. The only head-to-head GLP-1 RCT (Lundgren et al., 2021) showed combining exercise with liraglutide roughly doubled body-fat-percentage reduction versus either alone.
-
No GLP-1-specific contraindication has been published for creatine monohydrate at 3 to 5 grams per day. Creatine supports strength adaptations, which is what you're trying to preserve. Discuss with your clinician. See our supplements guide for the full breakdown.
Ready to train so the scale drop is actually fat, not muscle?
Free 14-day trial. Full programming, full adaptation, no credit card traps at the end.